Clinical Trials Browser

Completed × Interventional × Basal Cell Nevus Syndrome × Clear all

NCT03467789 2024-10-17

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Phase 1 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT04893486 2024-08-29

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

Phase 2 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT03703310 2024-07-03

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Phase 3 Completed

174 enrolled 23 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT02017964 2023-01-09

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Phase 2 Completed

26 enrolled 14 charts

CNSDermatologic

Basal Cell Nevus Syndrome, Medulloblastoma

NCT00957229 2021-01-11

GDC-0449

Phase 2 Completed

41 enrolled 10 charts

Basal Cell Nevus Syndrome

NCT01556009 2020-11-02

Vismodegib

Phase 2 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT00489086 2020-10-29

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

Phase 2 Completed

36 enrolled 7 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Neoplasms

NCT02157623 2020-07-30

Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome

Phase NA Completed

3 enrolled 7 charts

Basal Cell Nevus Syndrome

NCT02762084 2020-07-23

Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients

Phase 2 Completed

17 enrolled 22 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT02828111 2019-01-08

BCC

Phase 2 Completed

36 enrolled 17 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT02550678 2018-06-06

ASN-002-001

Phase 1/2 Completed

Basal Cell Nevus Syndrome, Skin Neoplasms

NCT01893892 2017-08-04

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

Phase NA Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT02100371 2017-07-11

Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome

Phase NA Completed

Basal Cell Nevus Syndrome

NCT00433485 2016-09-23

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

Phase 1 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Neoplasms

NCT00783965 2016-02-11

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

Phase 2 Completed

34 enrolled 9 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT00961896 2015-11-03

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Phase 2 Completed

18 enrolled 13 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT01350115 2015-10-19

Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Phase 2 Completed

10 enrolled 9 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell